Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Hordeolum and Stye : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Multimedia
References

Related Articles
Chalazion

Conjunctivitis

Corneal Abrasion




Patient Education
Eye and Vision Center

Chalazion Overview

Chalazion Causes

Chalazion Symptoms

Chalazion Treatment

Sty Overview




Author: Michael Bessette, MD, Director of Emergency Medicine, Bayonne Medical Center

Michael Bessette is a member of the following medical societies: American College of Emergency Physicians

Editors: Robin R Hemphill, MD, MPH, Associate Professor, Director, Disaster Preparedness, Department of Emergency Medicine, Vanderbilt University Medical Center; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Douglas Lavenburg, MD, Clinical Professor, Department of Emergency Medicine, Christiana Care Health Systems; John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center; Rick Kulkarni, MD, Medical Director, Assistant Professor of Surgery, Section of Emergency Medicine, Yale-New Haven Hospital

Author and Editor Disclosure

Synonyms and related keywords: chalazion, chalazia, infection of the eyelid margin, inflammation of the eyelid margin, external hordeolum, internal hordeolum, Staphylococcus aureus, Zeiss sebaceous glands, Moll sebaceous glands, meibomian glands, blepharitis, diabetes, seborrhea

Background

A hordeolum (ie, stye) is a localized infection or inflammation of the eyelid margin involving hair follicles of the eyelashes (ie, external hordeolum) or meibomian glands (ie, internal hordeolum). A chalazion is a painless granuloma of the meibomian glands.

A hordeolum usually is painful, erythematous, and localized. It may produce edema of the entire lid. Purulent material exudes from the eyelash line in external hordeola, while internal hordeola suppurate on the conjunctival surface of eyelid.

Pathophysiology

Staphylococcus aureus is the infectious agent in 90-95% of cases of hordeolum.

An external hordeolum arises from a blockage and infection of Zeiss or Moll sebaceous glands. An internal hordeolum is a secondary infection of meibomian glands in the tarsal plate. Both types can arise as a secondary complication of blepharitis.

Untreated, the disease may spontaneously resolve or it may progress to chronic granulation with formation of a painless mass known as a chalazion. Chalazia can be quite large and can cause visual disturbance by deforming the cornea. Generalized cellulitis of the eyelid may occur if an internal hordeolum is untreated.

Most morbidity is secondary to improper drainage. Proper technique and drainage precautions are described in Treatment.

Frequency

United States

Exact incidence of the disease is unknown, but it is a common entity.

International

No difference exists between US and international occurrence.

Sex

No sexual predilection exists.

Age

A slight increase in incidence is observed in the third to fifth decades of life.



History

  • Patients usually complain of a localized painful swelling on one eyelid.
  • In some cases, the complaint may start as a generalized edema and erythema of the lid that later becomes localized.
  • A history of similar problems is common.
  • Constitutional signs and symptoms are inconsistent with a hordeolum diagnosis. In extreme cases, the infection can spread to involve the entire lid and even the periorbital tissues. Such cases do not respond to normal hordeolum management and must be managed as periorbital cellulitis.

Physical

Completely examine the area around the orbit, the eye, and the conjunctival surface. Carefully inspect the underside of the eyelid to avoid missing an internal hordeolum.

  • Examination reveals a localized tender area of swelling with a pointing eruption either on the internal or on the external side of eyelid.
  • Occasionally, the hordeolum points on both sides.
  • Infection of conjunctiva is a common secondary finding.
  • Examination of preauricular nodes can help to identify spread of the disease beyond a simple hordeolum. Nodes should not be swollen in patients with a simple hordeolum.
  • No intraocular pathology should be found.
  • Presence of fever or distant nodes indicates systemic disease.

Causes

  • Staphylococcal organisms are the most common causes of eyelid infections, but other organisms may be involved.
  • Hordeola are found more frequently in persons who have the following:
    • Diabetes
    • Other debilitating illness
    • Chronic blepharitis
    • Seborrhea
    • High serum lipids (High lipid levels increase the blockage rate of sebaceous glands, but lowering of serum lipid levels in these patients has not decreased frequency of recurrence.)



Chalazion
Conjunctivitis
Corneal Abrasion

Other Problems to be Considered

Blepharitis
Eyelid neoplasms



Lab Studies

  • No laboratory studies are indicated.
  • Colonization with noninvasive bacteria is common, and bacterial cultures of material from the area generally do not correlate with clinical improvement.
  • Conjunctival bacteria culture results are positive in as many as 70% of asymptomatic persons with a hordeolum. S aureus is the most likely organism discovered, but cultures of the eyelid are more likely to obtain Staphylococcus epidermidis. For this reason, eye cultures are of little clinical value.
  • Blood tests are of no value in a simple hordeolum, but generalized eyelid cellulitis requires a more complete evaluation. If the infection is not well localized, a CBC and blood culture are required, and ophthalmologic consultation is indicated.



Emergency Department Care

  • Drainage of a hordeolum
    • Perform drainage with stab incisions at the site of pointing using an 18-gauge needle or a #11 blade. External incisions lead to scarring, so making external eyelid incisions or punctures is inadvisable, unless the hordeolum already is pointing externally.
    • A large abscess may have multiple pockets and require multiple stabs.
    • Internal incisions should be made vertically to minimize the area of cornea swept by a scar during blinking; external incisions should be made horizontally for optimal cosmesis.
    • Hold the lesion with a chalazion clamp.
    • To avoid disrupting normal growth of lashes, do not make incisions along eyelash margins.
    • Leave the incision open with a clean margin.
    • When draining a lesion that points both externally and internally, make the incision internally and as far as possible from the site of external pointing. Combined overlying internal and external drainage increases the risk of later fistulae through the lid.
    • Do not inject local anesthesia directly into the hordeolum; inject along the lid margins in a line above the upper tarsus or below the lower tarsus.
    • Do not attempt to remove all seemingly purulent material if acute inflammation is present; excessive loss of tarsal tissue and lid deformity may result.
  • Hordeola usually are self-limited even without drainage. Most hordeola eventually point and drain by themselves.
  • Warm soaks (qid for 15 min) are the mainstays of treatment.
  • Antibiotics are indicated only when inflammation has spread beyond the immediate area of the hordeolum.
    • Topical antibiotics may be used for recurrent lesions and for those that are actively draining. Topical antibiotics do not improve the healing of surgically drained lesions.
    • Systemic antibiotics are indicated if signs of bacteremia are present or if the patient has tender preauricular lymph nodes.
  • Surgical drainage of pointed lesions speeds the healing process.
    • If the lesion points at a lash follicle, removal of that one eyelash hair may promote drainage and healing.
    • Exercise caution when removing a lash, because removal of multiple lashes may result in disfigurement.

Consultations

  • If the patient does not respond to conservative therapy (ie, warm compresses, antibiotics) within 2-3 days, consult with an ophthalmologist.
  • Consultation with an ophthalmologist is recommended prior to drainage of large lesions that may have a higher likelihood of complications.



Start therapy with a topical treatment. Progress to systemic therapy only if signs and symptoms of severe infection are found.

Drug Category: Antibiotics

Topical antibiotics are useful for control of staphylococcal infections in eyelids and nares.

Drug NameBacitracin ophthalmic ointment (AK-Tracin)
DescriptionPrevents transfer of mucopeptides into growing cell wall; inhibits bacterial cell wall synthesis.
Adult DoseSevere infections: 0.25- to 0.50-in ribbon q3-4h for 7-10 d into conjunctival sac(s)
Mild-to-moderate infections: Apply bid/tid
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; vaccinia; varicella; epithelial herpes simplex keratitis; mycobacterial infections; fungal diseases of the eye; patients using steroid combinations after uncomplicated removal of a corneal foreign body
InteractionsNone reported
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsOphthalmic ointments may delay healing of corneal epithelia; in deep seated infections of the eye, supplement with systemic medications; prolonged use may result in overgrowth of nonsusceptible organisms

Drug NameTobramycin ophthalmic solution or ointment (Tobrex, AKTob)
DescriptionInterferes with bacterial protein synthesis by binding to 30S and 50S ribosomal subunits, which results in a defective bacterial cell membrane; available as solution, ointment, and lotion
Adult DoseSolution: 1-2 gtt q4h during waking hours and less frequently at night; in severe infections, instill 2 gtt q30-60min initially, followed by less frequent intervals
Ointment: Apply 0.5-inch ribbon in conjunctival sac bid/tid; in severe infections, apply q3-4h
Pediatric Dose<2 years: Not established
>2 years: Administer as in adults
ContraindicationsDocumented hypersensitivity
InteractionsEffects decrease when used concurrently with gentamicin
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsDo not use in deep-seated ocular infections or in those that may become systemic; prolonged use of antibiotics may result in bacterial or fungal overgrowth of nonsusceptible organisms

Drug NameErythromycin (EES, E-Mycin, Ery-Tab)
DescriptionFirst-choice treatment when systemic therapy is indicated; also indicated for treatment of infections caused by susceptible strains of microorganisms, including S aureus.
Adult Dose250 mg erythromycin stearate/base (or 400 mg ethylsuccinate) q6h PO 1 h ac, or 500 mg q12h
Alternatively, 333 mg PO q8h; increase to 4 g/d depending on severity of infection
Pediatric Dose30-50 mg/kg/d (15-25 mg/lb/d) PO divided q6-8h; double dose for severe infection
ContraindicationsDocumented hypersensitivity; hepatic impairment
InteractionsCoadministration may increase toxicity of theophylline, digoxin, carbamazepine, and cyclosporine; may potentiate anticoagulant effects of warfarin; coadministration with lovastatin and simvastatin increases risk of rhabdomyolysis
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsCaution in liver disease; estolate formulation may cause cholestatic jaundice; GI adverse effects are common (give doses pc); discontinue use if nausea, vomiting, malaise, abdominal colic, or fever occur

Drug NameDicloxacillin (Dycill, Dynapen)
DescriptionFor treatment of infections caused by penicillinase-producing staphylococci. May be used to initiate therapy when a staphylococcal infection is suspected.
Adult Dose125-250 mg PO q6h
Pediatric Dose<40 kg: 12.5 mg/kg/d PO divided q6h
>40 kg: 125 mg PO q6h
ContraindicationsDocumented hypersensitivity
InteractionsDecreases efficacy of oral contraceptives; increases effects of anticoagulants; probenecid and disulfiram may increase penicillin levels
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsMonitor PT in patients taking anticoagulant medications; toxicity may increase in patients renally impaired

Drug NameTetracycline (Sumycin)
DescriptionTreats susceptible bacterial infections of both gram-positive and gram-negative organisms as well as infections caused by mycoplasmal, chlamydial, and rickettsial organisms; inhibits bacterial protein synthesis by binding with 30S and possibly 50S ribosomal subunit(s) of susceptible bacteria
Adult DoseMild-to-moderate infections: 500 mg PO bid or 250 mg PO qid for 7-14 d
Severe infections: 500 mg PO qid for 7-14 d
Pediatric Dose<8 years: Not recommended
>8 years: 10-20 mg/lb/d PO (25-50 mg/kg/d) divided qid
ContraindicationsDocumented hypersensitivity; severe hepatic dysfunction
InteractionsBioavailability decreases with antacids containing aluminum, calcium, magnesium, iron, or bismuth subsalicylate; can decrease effects of oral contraceptives, causing breakthrough bleeding and increased risk of pregnancy; tetracyclines can increase hypoprothrombinemic effects of anticoagulants
PregnancyD - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
PrecautionsPhotosensitivity may occur with prolonged exposure to sunlight or tanning equipment; reduce dose in renal impairment; consider drug serum level determinations in prolonged therapy; tetracycline use during tooth development (last one half of pregnancy through age 8 y) can cause permanent discoloration of teeth; Fanconilike syndrome may occur with outdated tetracyclines

Drug NameCloxacillin (Cloxapen, Tegopen)
DescriptionFor treatment of infections caused by penicillinase-producing staphylococci. May be used to initiate therapy when a staphylococcal infection is suspected.
Adult Dose250-500 mg PO q6h
Pediatric Dose<20 kg: 50-100 mg/kg/d PO divided q6h
>20 kg: 250 mg PO q6h
ContraindicationsDocumented hypersensitivity
InteractionsDecreases efficacy of oral contraceptives; may decrease effects of anticoagulants; probenecid and disulfiram may increase penicillin levels
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsMonitor PT in patients taking anticoagulant medications; toxicity may increase in patients renally impaired



Further Outpatient Care

  • All patients should seek follow-up care with an ophthalmologist within 1-2 weeks if the condition is not resolved completely with conservative management.

In/Out Patient Meds

  • Patients should use warm compresses 3-4 times per day.

Deterrence/Prevention

  • Cleaning of eyelashes or removal of a few affected lashes may improve drainage and reduce recurrence.

Complications

  • The most frequent complication is progression to a chalazion that causes cosmetic deformity, corneal irritation, or the need for surgical removal.
  • Complications of improper drainage are disruption of lash growth, lid deformity, or lid fistula.
  • Generalized eyelid cellulitis may develop if an internal hordeolum is untreated.

Prognosis

  • Spontaneous healing is common.
  • Frequent recurrences are common.
  • Progression to systemic infection is rare; only a few case reports appear in the current literature.

Patient Education

  • Instruct patients on proper use of warm compresses and antibiotic use as described above.
  • For prevention, educate patients about lid hygiene.
  • Instruct patients not to squeeze a stye, because infection may spread to adjacent tissues.
  • For excellent patient education resources, visit eMedicine's Eye and Vision Center. Also, see eMedicine's patient education articles Chalazion (Lump in Eyelid) and Sty.



Media file 1:  Hordeolum pointing internally
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 2:  Internal side of the same hordeolum
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo



  • Barza M, Baum J. Ocular infections. Med Clin North Am. Jan 1983;67(1):131-52. [Medline].
  • Benton J, Karkanevatos A. Preseptal cellulitis due to Mycobacterium marinum. J Laryngol Otol. Jun 2007;121(6):606-8. [Medline].
  • Brafman AH. Styes: a curious chain. Br J Gen Pract. Dec 1992;42(365):537-8. [Medline].
  • Briner AM. Surgical treatment of a chalazion or hordeolum internum. Aust Fam Physician. Jun 1987;16(6):834-5. [Medline].
  • Briner AM. Treatment of common eyelid cysts. Aust Fam Physician. Jun 1987;16(6):828, 830. [Medline].
  • Diegel JT. Eyelid problems. Blepharitis, hordeola, and chalazia. Postgrad Med. Aug 1986;80(2):271-2. [Medline].
  • Hirunwiwatkul P, Wachirasereechai K. Effectiveness of combined antibiotic ophthalmic solution in the treatment of hordeolum after incision and curettage: a randomized, placebo-controlled trial: a pilot study. J Med Assoc Thai. May 2005;88(5):647-50. [Medline].
  • Jackson TL, Beun L. A prospective study of cost, patient satisfaction, and outcome of treatment of chalazion by medical and nursing staff. Br J Ophthalmol. Jul 2000;84(7):782-5. [Medline].
  • Lederman C, Miller M. Hordeola and chalazia. Pediatr Rev. Aug 1999;20(8):283-4. [Medline].
  • Olson MD. The common stye [published erratum appears in J Sch Health 1991 Mar;61(3):138]. J Sch Health. Feb 1991;61(2):95-7. [Medline].
  • Pavan-Langston D. Diagnosis and therapy of common eye infections: bacterial, viral, fungal. Compr Ther. May 1983;9(5):33-42. [Medline].
  • Raskin EM, Speaker MG, Laibson PR. Blepharitis. Infect Dis Clin North Am. Dec 1992;6(4):777-87. [Medline].

Hordeolum and Stye excerpt

Article Last Updated: Mar 11, 2008